RCSI

RCSI Bahrain Nursing Programmes receive Saudi Accreditation

Retrieved on: 
Sunday, January 29, 2023
University, Supreme Education Council (Qatar), RCSI-Bahrain, Medical school, Learning, Employment, Ministry, Royal College of Surgeons in Ireland, Patient, Education, RCSI, Nursing, Accreditation, Royal college, Trustee

BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.

Key Points: 
  • BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.
  • The Ministry of Education in Saudi Arabia has awarded accreditation to RCSI Bahrain's nursing undergraduate and postgraduate programmes.
  • As a result, Saudi nationals interested in pursuing a career in nursing as well as a postgraduate nursing degree will now be able to complete their qualification from RCSI Bahrain and subsequently join the nursing workforce in their home country or abroad.
  • RCSI Bahrain looks forward to supporting the advancement of the nursing workforce in support of improved health outcomes for all patients and people in the Gulf Cooperation Countries.

RCSI Bahrain Nursing Programmes receive Saudi Accreditation

Retrieved on: 
Sunday, January 29, 2023
University, Supreme Education Council (Qatar), RCSI-Bahrain, Medical school, Learning, Employment, Ministry, Royal College of Surgeons in Ireland, Patient, Education, RCSI, Nursing, Accreditation, Royal college, Trustee

BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.

Key Points: 
  • BUSAITEEN, Bahrain, Jan. 29, 2023 /PRNewswire/ -- The Royal College of Surgeons in Ireland – Medical University of Bahrain (RCSI Bahrain) has announced receiving accreditation for its nursing programmes from the Ministry of Education in Saudi Arabia.
  • The Ministry of Education in Saudi Arabia has awarded accreditation to RCSI Bahrain's nursing undergraduate and postgraduate programmes.
  • As a result, Saudi nationals interested in pursuing a career in nursing as well as a postgraduate nursing degree will now be able to complete their qualification from RCSI Bahrain and subsequently join the nursing workforce in their home country or abroad.
  • RCSI Bahrain looks forward to supporting the advancement of the nursing workforce in support of improved health outcomes for all patients and people in the Gulf Cooperation Countries.

RCSI research explains how our body clock influences vaccine responses

Retrieved on: 
Tuesday, December 6, 2022
School, Vaccination, B cell, Biomolecule, SFI, European Research Council, Research, RCSI, Steroidogenic acute regulatory protein, Mitochondrion, Spanish National Research Council, CDA, Human, Vaccine, Immunity, Nature Communications, Irish Research Council, Pharmacy

DUBLIN, Dec. 6, 2022 /PRNewswire/ -- Research by RCSI University of Medicine and Health Sciences has provided new insights into the mechanism behind how our circadian 24-hour body clock influences our immune response to vaccines, depending on the time of day.

Key Points: 
  • DUBLIN, Dec. 6, 2022 /PRNewswire/ -- Research by RCSI University of Medicine and Health Sciences has provided new insights into the mechanism behind how our circadian 24-hour body clock influences our immune response to vaccines, depending on the time of day.
  • This research has uncovered that our circadian clock is changing the shape of mitochondria within dendritic cells.
  • We can apply this understanding in vaccine development to ensure we receive the maximum benefits from vaccination."
  • Further support was provided by a Conacyt grant, a SFI Investigator Award and a European Research Council Consolidator Award.

Pathfinder Reports Record Revenues in the Third Quarter 2022

Retrieved on: 
Tuesday, November 29, 2022
Cloud, Marketing, NXT TakeOver, Growth, Adjustment, Johnnie Walker RV, COVID-19, EBITDA, Wainwright Securities Inc. v. Wall Street Transcript Corp., Disclosure, IIROC, Multimedia, Pathfinder, RCSI, TSX Venture Exchange, File, News, Tax, Agreement, Corporation, Oak Hill, Depreciation, Corporate communication, Person, Tourism, Bookkeeping, Video game, Security (finance), RV

Net loss from operations decreased to -$121,136 compared to -$172,679 in the same prior year period driven by the increased revenues.

Key Points: 
  • Net loss from operations decreased to -$121,136 compared to -$172,679 in the same prior year period driven by the increased revenues.
  • Increased revenues were largely due to all three sites being fully operational in Q2 2022 and mostly same period growth in Q3 2022.
  • Q1 2022 revenues were impacted by severe winter flooding in November 2021, the damage and repair work of which impacted site occupancies.
  • Pathfinder Ventures Inc. is developing a network of branded, upscale and family-friendly RV parks and campgrounds under the "Pathfinder Camp Resorts" name.

RCSI Bahrain announces a new global university partnership

Retrieved on: 
Thursday, November 24, 2022
Student, RCSI, Business and Technology Education Council, Royal college, Ministry of Education (Malaysia), Medical school, Keele University, Partnership, Excellency, Trustee, Royal College of Surgeons in Ireland, Knowledge, Kingdom, School, Research, Education, University, Learning, Practitioner, Health, RCSI-Bahrain, Patient, Medicine, Midwifery, Nursing

BUSAITEEN, Bahrain, Nov. 24, 2022 /PRNewswire/ -- The Royal College of Surgeons in Ireland Medical University of Bahrain (RCSI Bahrain) has announced details of a new global university partnership involving its School of Nursing and Midwifery.

Key Points: 
  • BUSAITEEN, Bahrain, Nov. 24, 2022 /PRNewswire/ -- The Royal College of Surgeons in Ireland Medical University of Bahrain (RCSI Bahrain) has announced details of a new global university partnership involving its School of Nursing and Midwifery.
  • This partnership is part of the University's strategic aim to prepare its graduates to become global healthcare professionals.
  • RCSI Bahrain is a constituent university of the Royal College of Surgeons in Ireland, which was established in Dublin, Ireland, in 1784.
  • RCSI Bahrain, an independent private university, opened its doors to a cohort of 28 medical students in 2004.

RCSI Bahrain announces a new global university partnership

Retrieved on: 
Thursday, November 24, 2022
Student, RCSI, Business and Technology Education Council, Royal college, Ministry of Education (Malaysia), Medical school, Keele University, Partnership, Excellency, Trustee, Royal College of Surgeons in Ireland, Knowledge, Kingdom, School, Research, Education, University, Learning, Practitioner, Health, RCSI-Bahrain, Patient, Medicine, Midwifery, Nursing

BUSAITEEN, Bahrain, Nov. 24, 2022 /PRNewswire/ -- The Royal College of Surgeons in Ireland Medical University of Bahrain (RCSI Bahrain) has announced details of a new global university partnership involving its School of Nursing and Midwifery.

Key Points: 
  • BUSAITEEN, Bahrain, Nov. 24, 2022 /PRNewswire/ -- The Royal College of Surgeons in Ireland Medical University of Bahrain (RCSI Bahrain) has announced details of a new global university partnership involving its School of Nursing and Midwifery.
  • This partnership is part of the University's strategic aim to prepare its graduates to become global healthcare professionals.
  • RCSI Bahrain is a constituent university of the Royal College of Surgeons in Ireland, which was established in Dublin, Ireland, in 1784.
  • RCSI Bahrain, an independent private university, opened its doors to a cohort of 28 medical students in 2004.

Theralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory

Retrieved on: 
Monday, November 7, 2022
Doctor of Philosophy, Precision medicine, Company, Protein, Royal College of Surgeons in Ireland, George Mason University, Private Securities Litigation Reform Act, Research, Neck, Universitas Nasional, OTC, FDA, Disease, Quality of life, LDT, CEO, Head, Lung, Prostate, U.S. Securities and Exchange Commission, Forward-looking statement, Royal college, Molecular medicine, Drug development, British Journal of Cancer, Liver, Security (finance), NIH, Breast cancer, Patient, RCSI, Oncology, Pharmaceutical industry, Cancer

GOLDEN, Colo., Nov. 7, 2022 /PRNewswire/ -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay for breast cancer, today announced that it has appointed Dr. Mattia Cremona as its Director of its Biopharma Laboratory effective November 7, 2022.

Key Points: 
  • GOLDEN, Colo., Nov. 7, 2022 /PRNewswire/ -- Theralink Technologies , Inc.(OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay for breast cancer, today announced that it has appointed Dr. Mattia Cremona as its Director of its Biopharma Laboratory effective November 7, 2022.
  • Dr. Cremona is a molecular biologist, with a specialty in translation oncology research.
  • He has contributed articles to several leading peer-reviewed journals, including Cancer and The British Journal of Cancer.
  • Theralink Technologies is a proteomics-based, precision medicine company with a CLIA-certified laboratory located in Golden, Colorado.

RCSI Bahrain Alumni Community on the rise in UK

Retrieved on: 
Tuesday, October 4, 2022
Student, Queen Elizabeth Hospital, King's Lynn, Ministry of Education (Malaysia), RCSI-Bahrain, Royal Society, Class, Nursing, Research, REQ, Medical school, Community, Faculty, Health, Royal College of Surgeons in Ireland, Queen Elizabeth Hospital, PLAB, Gulf Cooperation Council, General Medical Council, Education, Foundation doctor, GCC, NHS, Professional and Linguistic Assessments Board, Foundation, School, Reunion, Royal, Patient, RSM, GMC, Core, RCSI, Royal college, Medicine, Midwifery

With the opportunity to connect with alumni, Professor Sameer Otoom, President of RCSI Bahrain led a feedback session and discussed new ideas and initiatives with the alumni.

Key Points: 
  • With the opportunity to connect with alumni, Professor Sameer Otoom, President of RCSI Bahrain led a feedback session and discussed new ideas and initiatives with the alumni.
  • Since 2010, RCSI Bahrain has 282 alumni from more than 30 nationalities currently working in the UK, making the UK the most prominent destination for our alumni community after Bahrain.Therefore, as part of RCSI Bahrain's ongoing commitment towards our alumni, weare pleased to collaborate with the Royal Society of Medicine to support first year graduates in their career development."
  • This eases the process of accessing internship and postgraduate training opportunities for all RCSI Bahrain medical graduates in the UK, regardless of their nationality.
  • The RCSI Bahrain alumni network now consists of over 2,700 practising professionals in over 30 countries.

RCSI Bahrain Alumni Community on the rise in UK

Retrieved on: 
Tuesday, October 4, 2022
Student, Queen Elizabeth Hospital, King's Lynn, Ministry of Education (Malaysia), RCSI-Bahrain, Royal Society, Class, Nursing, Research, REQ, Medical school, Community, Faculty, Health, Royal College of Surgeons in Ireland, Queen Elizabeth Hospital, PLAB, Gulf Cooperation Council, General Medical Council, Education, Foundation doctor, GCC, NHS, Professional and Linguistic Assessments Board, Foundation, School, Reunion, Royal, Patient, RSM, GMC, Core, RCSI, Royal college, Medicine, Midwifery

With the opportunity to connect with alumni, Professor Sameer Otoom, President of RCSI Bahrain led a feedback session and discussed new ideas and initiatives with the alumni.

Key Points: 
  • With the opportunity to connect with alumni, Professor Sameer Otoom, President of RCSI Bahrain led a feedback session and discussed new ideas and initiatives with the alumni.
  • Since 2010, RCSI Bahrain has 282 alumni from more than 30 nationalities currently working in the UK, making the UK the most prominent destination for our alumni community after Bahrain.Therefore, as part of RCSI Bahrain's ongoing commitment towards our alumni, weare pleased to collaborate with the Royal Society of Medicine to support first year graduates in their career development."
  • This eases the process of accessing internship and postgraduate training opportunities for all RCSI Bahrain medical graduates in the UK, regardless of their nationality.
  • The RCSI Bahrain alumni network now consists of over 2,700 practising professionals in over 30 countries.

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, August 8, 2022
Biotechnology, Health, Pharmaceutical, Clinical Trials, Cardiology, Secondary research, Precision medicine, NYSE, IND, ACM, Degenerative disease, American College, Patient, University, RCSI, Biology, Â, Second Half, Heart, Arrhythmogenic cardiomyopathy, RCOR, AAV, Pharmaceutical industry

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, today reported financial results for the second quarter of 2022 and provided a corporate update.

Key Points: 
  • Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, today reported financial results for the second quarter of 2022 and provided a corporate update.
  • The progress achieved at Renovacor this quarter enabled us to advance and expand our pipeline of precision AAV gene therapies that target the underlying drivers of devastating cardiovascular diseases, said Magdalene Cook, M.D., Chief Executive Officer of Renovacor.
  • To accelerate this program, Renovacor entered into a research collaboration with the University of Utahs Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI).
  • The terms of the research agreement grant Renovacor an option for an exclusive license to inventions generated from research conducted under the collaboration.